Alzheimer's disease management is entering a new era with advances in disease-modifying therapies and evolving diagnostic approaches. To keep you updated on the latest clinical evidence, Eli Lilly invites you to an insightful scientific session on Lormalzi, featuring renowned geriatrician Dr. Paul Yates and neurologists Dr. P. Satishchandra and Dr.
Suvarna Alladi. The faculty will share expert perspectives on the urgency of treating Alzheimer's disease, patient identification, the efficacy and long-term extension evidence of Lormalzi (donanemab), real-world case discussions, and practical approaches to ARIA monitoring and management. Join the experts on August 1 , 2026 , at 6:00 PM IST to explore current evidence and practical considerations for integrating disease-modifying therapy into Alzheimer's disease care. Engage with the faculty and fellow clinicians in this interactive…
